RT Journal Article
T1 Photosensitive rash induced by nivolumab.
A1 Navarro-Triviño, Francisco J
A1 Ruiz-Villaverde, Ricardo
K1 Melanoma
K1 Patch tests
K1 Photobiology
AB The therapeutic approach to metastatic melanoma has revolutionized the clinical course of this disease. Since 2011, different immunotherapeutic drugs have been approved. Nivolumab is a humanized immunoglobulin IgG4 monoclonal antibody that binds to the PD-1 receptor, blocking its interaction with his ligand PD-L1. The authors present a new case of photosensitivity induced by nivolumab. The photo exposed distribution of the eruption, the sun exposure prior to the beginning of the eruption, and the chronological relationship with the beginning of the treatment are data that have allowed us to confirm the suspected clinical diagnosis.
YR 2022
FD 2022-07-07
LK http://hdl.handle.net/10668/21850
UL http://hdl.handle.net/10668/21850
LA en
DS RISalud
RD Apr 10, 2025